Anders D Hove's Net Worth

$498 Million

Estimate Recalculated Feb 29, 2024 07:04PM EST

Who is Anders D Hove?

Anders D Hove has an estimated net worth of $498 Million. This is based on reported shares across multiple companies, which include ARCA biopharma, Inc., Anacor Pharmaceuticals, Inc., Trubion Pharmaceuticals, Inc, Inspire Medical Systems, Inc., NEUROCRINE BIOSCIENCES INC, IRONWOOD PHARMACEUTICALS INC, Avalanche Biotechnologies, Inc., Edge Therapeutics, Inc., ALIMERA SCIENCES INC, Chelsea Therapeutics International, Ltd., and WORLD HEART CORP.

SEC CIK

Anders D Hove's CIK is 0001365618

Past Insider Trading and Trends

2010 was Anders D Hove's most active year for acquiring shares with 14 total transactions. Anders D Hove's most active month to acquire stocks was the month of September. 2016 was Anders D Hove's most active year for disposing of shares, totalling 19 transactions. Anders D Hove's most active month to dispose stocks was the month of March. 2010 saw Anders D Hove paying a total of $22,366,788.50 for 9,755,155 shares, this is the most they've acquired in one year. In 2015 Anders D Hove cashed out on 6,463,520 shares for a total of $115,209,962.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $136.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
0
0
Form 3
0
0
No matching records found

Avalanche Biotechnologies, Inc. (ADVM) Snapshot price: $2.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.37M
$17.00
2.37M
Aug 5
Form 3
0
0
No matching records found

Chelsea Therapeutics International, Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
Form 3
0
0
No matching records found

ARCA biopharma, Inc. (ABIO) Snapshot price: $1.58

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 30
Form 4
0
0
Dec 15
Form 4
0
0
Jan 12
Form 4
0
0
Mar 1
Form 4
0
0
Feb 16
Form 3
0
0
Form 3
0
0
No matching records found

Anacor Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-33.89K
$99.25
-$3,363,185.50
0
Jun 24
Form 4
-100.00%
-353.88K
$99.59
-$35,241,706.30
0
Scheduled
May 16
Form 4
+267.73%
257.65K
$31.05
$7,999,939.35
353.88K
Scheduled
Apr 14
Form 4
-70.44%
-229.30K
$71.10
-$16,303,945.12
96.23K
Scheduled
Apr 7 - Apr 8
Form 4
-73.44%
-900.00K
$111.25
-$100,125,000.00
325.54K
Dec 15
Form 4
-54.14%
-40.00K
$117.36
-$4,694,400.00
33.89K
Dec 11
Form 4
-23.55%
-400.19K
$103.60
-$10,390,562.00
1.3M
Nov 10
Form 4/A
-37.67%
-1.03M
1.7M
Nov 3
Form 4
-41.35%
-1.13M
1.6M
Nov 3
Form 4
794
794
Jun 9
Form 4/A
0
0
Oct 16
Form 4
0
0
Oct 16
Form 4
-0.73%
-20.00K
$25.00
-$500,000.00
2.73M
Scheduled
Sep 26
Form 4
-21.23%
-740.00K
$24.87
-$18,403,800.00
2.75M
Scheduled
Sep 18 - Sep 19
Form 4
-2.52%
-90.00K
$24.99
-$2,248,950.00
3.49M
Scheduled
Sep 12 - Sep 16
Form 4
0
0
May 29
Form 4
-4.03%
-150.00K
$14.06
-$2,109,000.00
3.58M
Nov 15
Form 4
0
0
Jun 6
Form 4
-0.51%
-19.27K
$6.30
-$121,456.52
3.73M
Sep 20
Form 4
-0.93%
-35.00K
$6.51
-$227,804.50
3.74M
Sep 14
Form 4
-0.66%
-25.18K
$6.59
-$165,932.26
3.78M
Sep 11 - Sep 13
Form 4
-17.74%
-820.55K
3.8M
Jul 2
Form 4
0
0
May 30
Form 4
0
0
May 25
Form 4
0
0
Mar 31
Form 4
4.63M
$5.00
4.63M
Nov 30
Form 3
0
0
No matching records found